Queen's Gazette | Queen's University

Search form

A national honour

Three Queen’s faculty members now invested as Officers of the Order of Canada.

  • Kerry Rowe promoted to Officer of the Order of Canada
    Kerry Rowe, a professor in the Department of Civil Engineering and former Vice-Principal (Research), is congratulated by Governor General Julie Payette upon being invested as an Officer of the Order of Canada. (Photo by Sgt. Johanie Maheu, Rideau Hall. © OSGG, 2018)
  • Elizabeth Eisenhauer promoted to Officer of the Order of Canada
    Professor Emerita Elizabeth Eisenhauer, the former director of the Canadian Cancer Trials Group, shakes hands with Governor General Julie Payette after being invested as an Officer of the Order of Canada. (Photo by Sgt. Johanie Maheu, Rideau Hall. © OSGG, 2018)
  • Paul Armstrong promoted to Officer of the Order of Canada
    Governor General Julie Payette congratulates Paul Armstrong, an adjunct professor in the School of Medicine, after he was invested as an Officer of the Order of Canada. (Photo by Sgt. Johanie Maheu, Rideau Hall. © OSGG, 2018)

The Right Honourable Julie Payette, Governor General of Canada, has recognized three Queen’s faculty members for their outstanding contributions to the country. Announced as recipients in January 2018, both Elizabeth Eisenhauer and R. Kerry Rowe were invested as Officers of the Order of Canada this month in Ottawa, while Paul Armstrong received the honour in September.

The Order of Canada is one of the country’s highest civilian honours and it recognizes those who make extraordinary contributions to the nation as exemplified in its motto Desiderantes Meliorem Patriam – “They desire a better country.” Since its creation in 1967, about 7,000 people have received the honour.

According to the Office of the Governor General, the Queen’s faculty members are recipients for the following reasons:

Elizabeth Ann Eisenhauer, O.C. (MD’76, Professor Emerita, Department of Oncology, former Director, NCIC Clinical Trials Group Investigational New Drug Program)

“Elizabeth Eisenhauer is an international leader in clinical cancer research. Professor emerita at Queen’s University and former director of the NCIC Clinical Trials Group Investigational New Drug Program, she has played an influential role in helping shape cancer treatment through key advancements in clinical trials. Notably, she led the design of criteria to evaluate the response of tumours to therapy, and evaluated numerous new drugs now used routinely in cancer treatment. Renowned for her experience and expertise, she has served on numerous international professional and institutional committees, benefiting oncology research worldwide.”

R. Kerry Rowe, O.C. (Professor, Department of Civil Engineering, former Vice-Principal (Research))

“Kerry Rowe is a passionate leader in the safeguarding of Canada’s natural resources. A professor at Queen’s University and a pioneer in geoenvironmental engineering, he is responsible for many of the designs, techniques and materials now used to manage waste disposal in the developed world. His seminal research on landfills has led to critical advancements in protecting land and water from contamination. Renowned for his dedication to the advancement of this field, he has served at the helm of numerous professional societies and institutional committees.”

Paul W. Armstrong, O.C. (Arts’63, MD’66 – Adjunct Professor, Queen’s School of Medicine)

“Paul Armstrong is a pioneering investigative and clinical cardiologist whose work in acute cardiac care has had global reach. A professor at the University of Alberta, he has conducted transformative research in the treatment of acute heart attacks and was instrumental in implementing this pre-hospital treatment in Alberta’s ambulances, which is credited with increasing patient survival rates. He is also recognized for his leadership in health care institutions, including as founding president of the Canadian Academy of Health Sciences and as director of the Canadian VIGOUR Centre, an international enterprise that conducts global-scale clinical trials in cardiovascular medicine.

For more information on other Order of Canada recipients with Queen’s connections see the Queen's Gazette and the Governor General's website.